0001213900-23-019577.txt : 20230313
0001213900-23-019577.hdr.sgml : 20230313
20230313162237
ACCESSION NUMBER: 0001213900-23-019577
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230310
FILED AS OF DATE: 20230313
DATE AS OF CHANGE: 20230313
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROCAMBOLI STEPHEN
CENTRAL INDEX KEY: 0001221451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39102
FILM NUMBER: 23727605
MAIL ADDRESS:
STREET 1: C/OPARMOUNT CAPITAL
STREET 2: 787 SEVENTH AVE 48TH FL
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TFF Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001733413
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 824344737
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: 737-802-1973
MAIL ADDRESS:
STREET 1: 2600 VIA FORTUNA, SUITE 360
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
ownership.xml
X0306
4
2023-03-10
0
0001733413
TFF Pharmaceuticals, Inc.
TFFP
0001221451
ROCAMBOLI STEPHEN
1751 RIVER RUN, SUITE 400
FORT WORTH
TX
76107
1
0
0
0
Common Stock
2023-03-10
4
P
0
13000
0.8025
A
16000
D
The reported shares were purchased in the open market in multiple transactions at prices ranging from $0.8025 to $0.8026. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
/s/ Stephen Rocamboli, by Kirk Allen Coleman, as Attorney-in-Fact
2023-03-13